SYNLAB Aktie

12,62EUR 0,00EUR 0,00%
SYNLAB für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A2TSL7 / ISIN: DE000A2TSL71
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023
Personal am Ende des Jahres 24 670 30 570 28 693 27 047
Umsatz pro Mitarbeiter in Mio. EUR 0,11 0,12 0,11 0,10

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023
Summe Umlaufvermögen 1 665 1 312 1 223 789
Summe Anlagevermögen 4 335 4 303 4 450 3 902
Summe Aktiva 5 283 5 426 5 381 4 663

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 3 129 2 046 2 117 1 561
Summe Fremdkapital 4 080 3 170 3 048 2 325
Summe Eigenkapital 1 204 2 256 2 333 2 338
Summe Passiva 5 283 5 426 5 381 4 663

Adresse

Moosacher Strasse 88, 80809 Munich
Telefon +49 (89) 307602-0
Fax +49 (89) 307602-190
Internet https://www.synlab.de

Management

Anastasya Molodykh-McFarlane
Member-Supervisory Board
Bartholomäus Wimmer
Independent Member-Supervisory Board
Catharina Monster
Chief Human Resources Officer
Christian Salling
Independent Member-Supervisory Board
David Raymond Ebsworth
Chairman-Supervisory Board
Henrik Andreasen
Chief Information Officer
Iris Schopper
Member-Supervisory Board
Karin Bierstedt
Member-Supervisory Board
Luis Miguel Vieira
Chief Strategy Officer
Marc Welters
Deputy Chairman-Supervisory Board
Mark Reinhard
Head-Investor Relations
Mathieu Olivier Floreani
Chairman-Management Board & CEO
Peter Anthony Colin Catterall
Member-Supervisory Board
Rene Schmidt-Ferroud
Member-Supervisory Board
Robert Steinwander
Chief Operating Officer
Sami Badarani
Chief Financial Officer
Santiago Valor Garcia
Chief Medical Officer
Stefan Graf
Member-Supervisory Board
Ute Hasholzner
Member-Supervisory Board
Walla Fabian
Group General Counsel